Concentrations of the atherogenic Lp(a) are elevated in FH

European Journal of Human Genetics

Volumn 6, Issue 1, 1998, Pages 50-60

  Lingenhel, Arno ^a   Kraft, Hans Georg ^a   Kotze, Maritha ^b   Peeters, Armand V ^b   Kronenberg, Florian ^a   Kruse, Rita ^c   Utermann, Gerd ^a,d  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF BONN   (Germany)

^d Inst F Med Biol und Humangenetik   (Austria)

Author keywords

Apo(a); Familial hypercholesterolaemia; Genotype; LDL receptor; Lipoprotein(a); Sib pair analysis

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CANADA; CORONARY RISK; ETHNIC GROUP; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE LOCUS; GENE MUTATION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SOUTH AFRICA; XANTHOMATOSIS;

EID: 0031952385     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200152     Document Type: Article

References (40)

1. Goldstein JL, Hobbs HH, Brown MS: Familial Hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS and Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill: New York,1995, II, pp 1981-2030.
2. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, Utermann G: Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990; 322: 1494-1499.
3. Utermann G: Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Stanbury JB, Wyngaarden JB, and Fredrickson DS (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill: New York, 1995, II, pp 1887-1912.
4. Sandholzer C, Hallman DM, Saha N et al: Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 66: 607-614.
5. Helmhold M, Bigge J, Muche R, Mainoo J, Thiery J, Seidel D, Armstrong VW: Contribution of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation. J Lipid Res 1991; 32: 1919-1928.
6. Kraft HG, Lingenhel A, Pang RWC et al: Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asia, and African populations: the distribution of null alleles is non-random. EJHG 1996; 4: 74-87.
7. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
8. Kraft HG, Köchl S, Menzel HJ, Sandholzer C, Utermann G: The apolipoprotein(a) gene - a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992; 90: 220-230.
9. Demeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI: Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am J Hum Genet 1995; 56: 287-293.
10. Sandholzer C, Feussner G, Brunzell JD, Utermann G: Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type-III hyperlipoproteinemia - no evidence for a triglyceriderich precursor of lipoprotein(a). J Clin Invest 1992; 90: 1958-1965.
11. Steyrer E, Durovic S, Frank S et al: The role of lecithin: cholesterol acyltransferase for lipoprotein(a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 1994; 94: 2330-2340.
12. Menzel HJ, Dieplinger H, Lackner C et al: Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma - indication for an assembly defect. J Biol Chem 1990; 265: 981-986.
13. Austin MA, Sandholzer C, Selby JV, Newman B, Krauss RM, Utermann G: Lipoprotein(a) in women twins - heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet 1992; 51: 829-840
14. Boomsma DI, Kaptein A, Kempen HJM, Leuven JAG, Princen HMG: Lipoprotein(a) - relation to other risk factors and genetic heritability - results from a Dutch parent-twin study. Atherosclerosis 1993; 99: 23-33.
15. Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson G; Boerwinkle E: Defects in the LDL receptor gene affect Lp(a) lipoprotein levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci USA 1989; 86: 4171-4174.
16. Leitersdorf E, Friedlander Y, Bard JM, Fruchart JC, Eisenberg S, Stein Y: Diverse effect of ethnicity on plasma lipoprotein(a) levels in heterozygote patients with familial hypercholesterolemia. J Lipid Res 1991; 32: 1513-1519.
17. Ghiselli G, Gaddi A, Barozzi G, Clarrocchi A, Descovich G: Plasma lipoprotein(a) concentration in familial hypercholesterolemic patients without coronary artery disease. Metabolism 1992; 41: 833-838.
18. Perombelon YNF, Soutar AK, Knight BL: Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest 1994; 93: 1481-1492.
19. Friedlander Y, Leitersdorf E: Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia. Genet Epidemiol 1995; 12: 129-143.
20. Carmena R, Lussler Cacan S, Roy M, Minnich A, Lingenhel A, Kronenberg F, Davignon J: Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterloscler Thromb Vasc Biol 1996; 16: 129-136.
21. Defesche JC, van de Ree MA, Kastelein JJ, van Diermen DE, Janssens NW, van Doormaal JJ, Hayden MR: Detection of the Pro664-Leu mutation in the low-density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and Canada. Clin Genet 1992; 42: 273-280.
22. 664-> leu mutation in the LDL receptor gene. J Clin Invest 1991; 88: 483-492.
23. Kotze MJ, Langenhoven E, Warnich L, du Plessis L, Retief AE: The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners. Ann Hum Genet 1991; 55: 115-121.
24. Kotze MJ, Theart L, Callis M, Peeters AV, Thiart R, Langenhoven E: Nonradioactive multiplex PCR screening strategy for the simultaneous detection of multiple lowdensity lipoprotein receptor gene mutations. PCR Methods Applic 1995; 4: 352-356.
25. Kotze MJ, Langenhoven E, Retief AE, et al: Haplotype associations of three DNA polymorphisms at the human low-density lipoprotein receplor gene locus in familial hypercholesterolemia. J Med Genet 1987; 24: 750-755.
26. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparalive ullracenlrifugalion. Clin Chem 1972; 18: 499-502.
27. Kronenberg F, Lobentanz E, König P, Ulermann G, Dieplinger H: Effect of sample storage on the measurement of lipoprolein(a), apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318-1328.
28. Kraft HG, Lingenhel A, Bader G, Kostner GM, Utermann G: The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1996; 125: 53-61.
29. Kamboh MI, Ferrell RE, Kottke BA: Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 1991; 49: 1063-1074.
30. Kraft HG, Dieplinger H, Hoye E, Utermann G: Lp (a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis 1988; 8: 212-216.
31. Cohen JC, Chiesa G, Hobbs HH: Sequence polymorphisms in the apolipoprotein(a) gene - evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest 1993; 91: 1630-1636.
32. Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL: Deletion in the gene for the LDL receptor in majority of French Canadians with familial hypercholeslerolemia. N Engl J Med 1987; 317: 734-737.
33. Van der Hoek YY, Lingenhel A, Kraft HG, Defesche JC, Kastelein JPP, Utermann G: Sib-pair analysis defects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familiar defective ApoB. J Clin Invest 1997; 99: 2269-2273.
34. De Coen J-L, Kocher J-P, Delcroix C, Lontle J-F, Malmendier CL: Conformational properties of apolipoproteins studied by computer graphics. Adv Exp Med Biol 1991; 285: 141-145.
35. Austin MA, Sandholzer C, Selby JV, Newman B, Krauss RM, Utermann G: Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet 1992; 51: 829-840.
36. Hofmann SL, Russell DW, Brown MS, Goldstein JL, Hammer RE: Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in trans-genic mice. Science 1988; 239: 1277-1281.
37. Rader DJ, Mann WA, Cain W et al: The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 1995; 95: 1403-1408.
38. Thiery J, Armstrong VW, Schleef J, Creutzfeldt C, Creutzfeldt W, Seidel D: Serum lipoprotein Lp(a) concentration are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr 1988; 66: 462-463.
39. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL: HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 1989; 80: 1313-1319.
40. Lasuncion MA, Teruel JL, Alvarez JJ, Carrero P, Ortuno J, Gomezcoronado D: Changes in lipoprotein(a), LDL-cholesterol and alipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL-apheresis. Eur J Clin Invest 1993; 23: 819-826.